LINC02626

Across TCGA pan-cancer cohorts, LINC02626 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated LINC02626 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher LINC02626 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated LINC02626 expression acts as an unfavorable survival marker, although some lineages such as MESO and READ show a favorable association.

MESO, READ, and KIRC are the cancer types where LINC02626 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	DFS	Quartile	All	0.492	0.295	.003	76	view →
READ	DFS	Tertile	III,IV	0.874	0.327	<.001	53	view →
KIRC	OS	Quartile	All	0.453	0.693	.001	30	view →
BLCA	OS	Median	All	0.674	0.554	.014	29	view →
ACC	DFS	Quartile	All	0.234	0.718	<.001	27	view →
THCA	OS	Quartile	II,III,IV	0.925	1.000	.001	25	view →
KIRP	OS	Median	III,IV	0.187	0.681	.003	20	view →
SKCM	DFS	Median	III,IV	0.382	0.151	.002	16	view →
LIHC	DFS	Tertile	III,IV	0.198	0.411	.009	15	view →
LUAD	DFS	Quartile	IV	0.167	0.761	.010	12	view →
LAML	DFS	Quartile	All	0.513	0.287	.020	12	view →
LUSC	DFS	Median	II,III,IV	0.630	0.784	.005	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

LINC02626–MESO (DFS)

Open the MESO breakdown →